← The Wire
DRUGNasdaq
BRIGHT MINDS BIOSCIENCES INC.
Pharmaceutical Preparations · A1 · CIK 1827401
Developing novel therapeutics for neurological and psychiatric disorders by targeting serotonin receptors
$598M
Market cap
$69.18
Last close
+5.2%
1D
+9.0%
5D
335K
Volume
Price · last 39 sessions-16.9%
May 4L $59.17 · H $89.49Jun 29
95
Total filings
Jun 3, 2026
Last filing
09/30
Fiscal year end
SC 13GSC 13GNov 12, 2024SC 13GSC 13GOct 25, 2024SC 13GSC 13GOct 23, 2024SC 13GBRIGHT MINDS BIOSCIENCES INC.Oct 23, 2024SC 13GSC 13GOct 22, 2024SC 13GSC 13GOct 16, 2024
Similar companies
Comparable business profile · signals at a glance